Selected Publications
Ng, C.G., Coppens, I., Govindarajan, D., Pisciotta, J., Shulaev, V. and Griffin, D.E. Effect of host cell lipid metabolism on alphavirus replication, virion morphogenesis, and infectivity. Proc. Natl. Acad. Sci. USA 105:16326-16331, 2008.
Sutcliffe, C.G., Scott, S., Mugala, N., Ndhlovu, Z., Monze M., Quinn, T.C., Cousens, S. Griffin D.E. and Moss, W.J. Survival from 9 months of age among HIV-infected and uninfected Zambian children prior to the availability of antiretroviral therapy. Clin. Infect. Dis. 47:837-844, 2008.
Pan, C-H, Jimenez, G., Nair, N., Wei, Q, Adams, R.J., Polack, F.P., Rolland, A., Vilalta, A. and Griffin, D.E. Use of Vaxfectin with DNA vaccine encoding the measles virus hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques against measles. Clin. Vaccine Immunol. 15:1214-1221, 2008.
Garcia, M. Yu, X.F., Griffin D.E. and Moss, W.J. Measles virus inhibits human immunodeficiency virus type 1 reverse transcription and replication by blocking cell-cycle progression of CD4+ T lymphocytes. J. Gen. Virol. 89:984-993, 2008.
Greene, I.P., Lee, E-Y, Prow, N., Ngwang, B. and Griffin, D.E. Protection from fatal viral encephalomyelitis: AMPA receptor antagonists have a direct effect on the inflammatory response to infection. Proc. Natl. Acad. Sci. USA 105:3575-3580, 2008.
Pan, C-H, Nair, N., Adams, R.J., Zink, M.C., Lee, E-Y, Polack F.P., Singh M., O’Hagan, D.T. and Griffin, D.E. Dose-dependent protection against or exacerbation of disease by a polylactide glycolide microparticle-adsorbed, alphavirus-based measles virus DNA vaccine in rhesus macaques. Clin. Vaccine Immunol. 15:697-706, 2008.
Moss, W.J., Fisher, C., Scott, S., Monze, M., Ryon, J.J., Quinn, T.C., Cutts, F. and Griffin D.E. HIV type 1 infection is a risk factor for mortality in hospitalized Zambian children with measles. Clin. Infect. Dis. 46:523-527, 2008.
Scott, S., Moss, W.J., Cousens, S., Beeler, J.A., Audet S.A., Mugala, N., Quinn, T.C., Griffin, D.E. and Cutts, F.T. The influence of HIV-1 exposure and infection on levels of passively acquired antibodies to measles virus in Zambian infants. Clin. Infect. Dis. 45:1417-1424, 2007.
Nair, N., Gans, H., Lew-Yasukawal, L., Long-Wagar, A.C., Arvin, A. and Griffin, D.E. Age-dependent differences in IgG isotype and avidity induced by measles vaccine received during the first year of life. J. Infect. Dis. 196:1339-1345, 2007.
Moss, W.J., Scott, S., Mugala, N., Ndhlovu, Z., Beeler, J., Andet, S., Ngala M., Mwangala, S., Nkonga-Mwangilwa, C., Ryon, J.J., Monze, M., Kasolo, F., Quinn, T.C., Cousens, S., Griffin, D.E. and Cutts, F.T. Immunogenicity of standard-titer measles vaccine in HIV-1-infected and uninfected Zambian children: an observational study. J. Infect. Dis. 196:347-355, 2007.
Ota, M.O., Ndhlovu, Z., Oh, S.K., Piyasirisilp, S., Berzofsky, J.A., Moss, W.J. and Griffin, D.E. The hemagglutinin protein is a primary target of the measles virus-specific HLA-A2-restricted CD8+ T cell response during measles and after vaccination. J. Infect. Dis. 195:1799-1807, 2007.
Riddell, M.A., Moss, W.J., Hauer, D., Monze, M. and Griffin, D.E. Slow clearance of measles virus RNA in children after acute measles. J. Clin. Virol. 39:312-317, 2007.
Zilliox, M.J., Moss, W.J. and Griffin, D.E. Gene expression changes in peripheral blood mononuclear cells during measles. Clin. Vaccine Immunol. 14:918-923, 2007.
Burdeinick-Kerr, R., Wind, J. and Griffin, D.E. Synergistic roles of antibody and interferon in noncytolytic clearance of Sindbis virus from different regions of the central nervous system. J. Virol. 81:5628-5636, 2007.
Ng, C.C. and Griffin, D.E. Defect in acid sphingomyelinase increases susceptibility to fatal alphavirus encephalomyelitis. J. Virol. 80:10989-10999, 2006.
Zilliox, M.J., Parmigiani, G. and Griffin D.E. Gene expression patterns in dendritic cells infected with measles virus compared with other pathogens. Proc. Natl. Acad. Sci. (USA) 103:3363-3368, 2006.
Bear, J.S., Byrnes, A.P. and Griffin, D.E. Recombinant strains of Sindbis virus with similar heparin-binding characteristics and distinct patterns of virulence. Virology 347:183-190, 2006.
Oh, S-K, Stegman, B., Pendleton, C.D., Ota, M.O., Pan, C-H, Griffin, D.E., Burke, D.S. and Berzofsky, J.A. Protective immunity provided by HLA-A2 epitopes for fusion and hemagglutinin proteins of measles virus. Virology 352:390-399, 2006.
Moss, W.J. and Griffin, D.E. Global measles elimination. Nat. Rev. Microbiol 4:900-908, 2006.
Pan, C-H, Valsamakis, A., Colella, T., Nair, N., Adams, R.J., Polack, F.P., Greer, C.E., Perri, S., Polo, J.M. and Griffin, D.E. Modulation of disease, T cell responses and measles virus clearance in monkeys vaccinated with H-encoding alphavirus replicon particles. Proc. Natl. Acad. Sci. (USA) 102:11581-11588, 2005.
Garcia, M., Yu, X.-F., Griffin, D.E. and Moss, W.J. In vitro suppression of human immunodeficiency virus type 1 replication by measles virus. J. Virol. 79:9197-9205, 2005.